Dopaminergic modulation of reward discounting in healthy rats: a systematic review and meta-analysis.

Psychopharmacology
Jaime J CastrellonGregory R Samanez-Larkin

Abstract

Although numerous studies have suggested that pharmacological alteration of the dopamine (DA) system modulates reward discounting, these studies have produced inconsistent findings. Here, we conducted a systematic review and pre-registered meta-analysis to evaluate DA drug-mediated effects on reward discounting of time, probability, and effort costs in studies of healthy rats. This produced a total of 1343 articles to screen for inclusion/exclusion. From the literature, we identified 117 effects from approximately 1549 individual rats. Using random effects with maximum-likelihood estimation, we meta-analyzed placebo-controlled drug effects for (1) DA D1-like receptor agonists and (2) antagonists, (3) D2-like agonists and (4) antagonists, and (5) DA transporter-modulating drugs. Meta-analytic effects showed that DAT-modulating drugs decreased reward discounting. While D1-like and D2-like antagonists both increased discounting, agonist drugs for those receptors had no significant effect on discounting behavior. A number of these effects appear contingent on study design features like cost type, rat strain, and microinfusion location. These findings suggest a nuanced relationship between DA and discounting behavior and urge cautio...Continue Reading

References

Feb 1, 1991·Experimental Neurology·J K WamsleyM E Alburges
Mar 1, 1991·Journal of the Experimental Analysis of Behavior·H RachlinD Cross
Sep 1, 1984·Naunyn-Schmiedeberg's Archives of Pharmacology·A ClosseH J Tobler
Apr 4, 2002·Psychological Methods·Scott B Morris, Richard P DeShon
Nov 15, 2002·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Frank P BymasterKenneth W Perry
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Xilu JiaoShanaz Tejani-Butt
Apr 7, 2005·Brain Research Bulletin·Sergio ZamudioGonzalo Flores
Sep 7, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Stan B FlorescoSarvin Ghods-Sharifi
Sep 11, 2007·Biochemical Pharmacology·Leonard L Howell, Heather L Kimmel
Feb 29, 2008·Trends in Pharmacological Sciences·Tommy Pattij, Louk J M J Vanderschuren
May 30, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Todd A HareAntonio Rangel
Aug 1, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Jennifer R St Onge, Stan B Floresco
Aug 30, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Claire McDermott, John P Kelly
Apr 1, 2009·Behavioral Neuroscience·Mark E BardgettLeonard Green
Apr 17, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Philip L ClatworthyTrevor W Robbins
Jul 23, 2009·Annals of Internal Medicine·David MoherUNKNOWN PRISMA Group
May 25, 2010·Psychopharmacology·Jennifer R St OngeStan B Floresco
Nov 6, 2010·Archives of Pharmacal Research·Dong Im ChoKyeong-Man Kim
Dec 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Manuela SellittoGiuseppe di Pellegrino
Jan 15, 2011·Trends in Pharmacological Sciences·Stefan LöberPeter Gmeiner
Feb 10, 2011·Pharmacological Reviews·Jean-Martin Beaulieu, Raul R Gainetdinov
Apr 21, 2011·Physiology & Behavior·Danielle R ReedMichael G Tordoff
Apr 29, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Adam C MarTrevor W Robbins
May 3, 2011·Biological Psychiatry·Roshan Cools, Mark D'Esposito
Jun 23, 2011·Behavioural Pharmacology·Mikhail N KoffarnusJames H Woods
Dec 2, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nicholas W SimonBarry Setlow
Jan 21, 2012·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nora D VolkowJames M Swanson
May 10, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Naghmeh ShafieiStan B Floresco
Jul 19, 2012·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sean B OstlundNigel T Maidment
Oct 9, 2012·Neuron·Nicolas X Tritsch, Bernardo L Sabatini
Nov 9, 2012·Journal of Psychopharmacology·Margery C PardeyJennifer L Cornish
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Colin M StopperStan B Floresco
Jun 26, 2014·The International Journal of Neuropsychopharmacology·S SommerW Hauber

❮ Previous
Next ❯

Citations

Aug 19, 2021·Molecular Psychiatry·Warren D TaylorBret R Rutherford
Nov 5, 2021·Translational Psychiatry·Cyril Atkinson-ClementYulia Worbe

❮ Previous
Next ❯

Software Mentioned

metafor
metafor R
R Statistics package

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

BioRxiv : the Preprint Server for Biology
Jaime J CastrellonGregory R Samanez-Larkin
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Jaime J CastrellonGregory R Samanez-Larkin
The Western Journal of Medicine
H Z Coren
© 2021 Meta ULC. All rights reserved